PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
Tytuł artykułu

Studies on Reactions of 3-Benzoyl-4-hydroxypyrido[3,2-e)-1,2-thiazines with Primary Amines and N-Methylhydrazine

Identyfikatory
Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
Reaction of the appropriate 3-benzoyl-4-hydroxypyrido[3,2-e]-1,2-thiazine-1,1-dioxides 2 bearing a methyl or a 3-(4-arylpiperazin-1-yl)propyl group at the nitrogen atom of the thiazine ring with primary amines resulted in enamines of type (E)-3. The related products 8 were obtained by alkylation of 3-phenylpyrazolo[4,3-c]pyrido[3,2-e]-1,2- thiazine-5,5-dioxide 7 with the corresponding 1-aryl-4-(3-chloropropyl)piperazines 9. The structures of the new heterocycles 3 and8, synthesized for pharmaceutical purposes, and of the model compounds 4-6, prepared for comparison of spectral properties, were proven through elemental, IR, 1H NMR and, in some cases (3d, 8a), X-ray data.
Rocznik
Strony
815--829
Opis fizyczny
Bibliogr. 30 poz., rys.
Twórcy
autor
  • Department of Chemistry of Drugs, Wrocław Medical University, ul. Tamka 1, 50-137 Wrocław, Poland
  • Department of Chemistry, University of Podlasie, ul. 3 Maja 54, 08-110 Siedlce, Poland
autor
  • ---
  • Department of Chemistry of Drugs, Wrocław Medical University, ul. Tamka 1, 50-137 Wrocław, Poland
autor
  • Department of Chemistry of Drugs, Wrocław Medical University, ul. Tamka 1, 50-137 Wrocław, Poland
  • Institute of Organic Chemistry, Polish Academy of Sciences, ul. Kasprzaka 44/54, 01-224 Warsaw, Poland
Bibliografia
  • 1. The Merck Index, Thirteenth Edition, 2001, p. 3755, 5848 and 9225.
  • 2. Zawisza T. and Malinka W., Farmaco, 41, 826 (1986).
  • 3. Malinka W., Ryng S., Sieklucka-Dziuba M., Rajtar G., Gtowniak A. and Kleinrok Z., Farmaco, 53,504 (1998).
  • 4. Malinka W., Sieklucka-Dziuba M., Rajtar-Cynke G., Borowicz K. and Kleinrok Z., Farmaco, 49, 783 (1994) ; Pol. Pat. 170394 (1996) and 170371 (1996).
  • 5. Malinka W., Kaczmarz M., Filipek B., Sapa J. and Głód. B., Farmaco, 57, 737 (2002).
  • 6. Zawisza T. and Malinka W., Farmaco, 41, 826 (1986).
  • 7. Karczmarzyk Z. and Malinka W., Acta Cryst., (2004), manuscript not accepted yet.
  • 8. Antimycobacterial data of compounds were provided by the U.S. Tuberculosis Antimicrobial Acquisi¬tion and Coordinating Facility (TAACF), NLAID/NIH Contract No. N01-A1-45246.
  • 9. Wiley R.H. and Wiley P., The Chemistry of Heterocyclic Compounds, A. Weissberger, Ed., Vol. 20, Interscience Publishers, London, 1964, and references cited therein.
  • 10. Malinka W., Sieklucka-Dziuba M., Rajtar-Cynke G., Gąsior M. and Kleinrok Z., Farmaco, 50, 29 (1995) .
  • 11. Malinka W., Redzicka A. and Świątek P., Acta Polon. Pharm.-Drug Research, 59, 439 (2002).
  • 12. Malinka W., Sieklucka-Dziuba M., Rajtar G., Rubaj A. and Kleinrok Z., Farmaco, 54, 390 (1999).
  • 13. Duax W.L. and Norton D.A., Atlas of Steroid Structures, Plenum Pres, NY, 1975.
  • 14. Allen F.H., Kennard O., Watson D.G., Brammer L., Orpen A.G. and Taylor R., Typical interatomic dis¬tances: organic compounds, in: International Tables for Crystallography, Vol. C, Kluwer Academic Publishers, Dordrecht/Boston/London, 1995, pp. 685-706.
  • 15. Allen F.H., The Cambridge Structural Database: a quarter of a million crystal structures and rising, Acta Cryst., B58, 380 (2002).
  • 16. Bruno I.J., Cole J.C., Edgington P.R., Kessler M., Macrae C.F., McCare P., Pearson J. and Taylor R,,Acta Cryst., B58, 389 (2002).
  • 17. FanghSnel E., Hucke A., BaumeisterU. andHartungH., J Prakt. Chem. Chem.-Zeit., 338,345 (1996).
  • 18. Kojic-Prodic B. and Ruzic-Toros Z., Acta Cryst., B38, 2948 (1982).
  • 19. Bordner J., Jeffrey J.A., Richards A., Weeks P. and Whipple E.B., Acta Cryst., C40, 989 (1984).
  • 20. Luger P., Daneck K., Engel W., Trummlitz G. and Wagner K., Eur. J. Pharm. Sci., 4, 175 (1996).
  • 21. Frigola J., J. Chem. Soc., Perkin Trans. II, 241 (1988).
  • 22. Theobald F., RodierN., Aubry C., CiamalaK. and Nguyen Dinh An, Acta Cryst., C50, 791 (1994).
  • 23. Sheldrick G.M., SHELXS-86, Program for crystal structure determination, University of Gottingen, Germany; Acta Cryst., A46, 467 (1990).
  • 24. Sheldrick G.M., SHELX-97 (Includes SHELXS-97, SHELXL-97, CIFTAB), Programs for crystal structure analysis Release 97-2, University of Gottingen, Germany, 1997.
  • 25. Farrugia L.J., ORTEP3 for Windows, J. Appl. Cryst., 18, 51 (1985).
  • 26. Nardelli M., PARST, A system of Fortran routines for calculating molecular structure parameters from results of crystal structure analysis, Comput. Chem., 7, 95 (1983).
  • 27. Spek A.L., PLATON/PLUTON, A multipurpose crystallographic tool, Utrecht University, Utrecht, The Netherlands, 1998.
  • 28. Farrugia L.J., WINGX, WinGX suite for small-molecule single-crystal crystallography, J. Appl. Cryst., 32, 1837(1999).
  • 29. MOLEN, Enraf-Nonius, Structure determination system, Version September 1999.
  • 30. Stoe & Cie, XRED, version 1.18, Data reduction program, Stoe & Cie GmbH, Darmstadt, Germany, 1999.
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-article-BUJ1-0024-0030
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.